{"name":"Ausper Biopharma Co., Ltd.","slug":"ausper-biopharma-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNYk5fUTdiZXJyZXNiS3ZQc1ZYRldqQ1BKQ2tEcVdqRlZ1U0o2dzNLSEwyU2o3czBDVnpKWC1aYnFJMVNUZ0hDZFRpS2trZGpzUGRJcXltYXoxYWdaLXhzems0VG1ObS1sRzdmUmJ1OFpnSHVwcXpCQXlvdVcxcjJOTWlVTHllcFZRWWItWGJneXI3cGdVb3lXS0RRRktkS0xYMGNqcTY2eXRWTHBTM0NrTGJvRjN6a2ctZWlKTzQyZFZMNWlTWDU1SzZINjh4bVdOVkUxMHhhSjAzX2QxZWMxUDM3MUxSbXVmdkJ2aFhZWGRKbU5IR19kVTN2WVJOSTZkOHpRWWdoVnFFTnNhaGc?oc=5","date":"2026-04-07","type":"trial","source":"Barchart.com","summary":"Hepatitis B Virus Infection Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com","headline":"Hepatitis B Virus Infection Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Trea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNLWV0R0hNcTZKdFZpSFBPdjlqRjdaYnFwbUl0cmRmb05OSjZUQTJ6R2ozS2dJQlpydW1qS3ZRY1BoSkRsR1hqQUZBYmEzVUNnRUtJUXI0UVlJOUlkOHZRLUYyNmF2TG1JWWhWZ1k0anoxLWp5UUxNaHphT2Y3V2FzMzRxR0Nfa2FIbnJHUGo1VQ?oc=5","date":"2026-02-07","type":"regulatory","source":"BioPharma Dive","summary":"Hims cancels plans to sell compounded GLP-1 pill after FDA backlash - BioPharma Dive","headline":"Hims cancels plans to sell compounded GLP-1 pill after FDA backlash","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPSklmMklGSUU0bks5cjV6VGxoZW1KWFdBTUVSaEVXRlhRMi1EbjZWOXl0Y1luTlBDaF9iUFpRb1Y2ZVlYMHEyR1ZSSnk5MHVtN21XMkJBaXdEU1JtbzlvQTI2YWdkMExlOXB6UHZqOC1CbUpNalkwMHd0U0llYlBVcmdnVHZvOGw4OUFiaVZJamVENzl5?oc=5","date":"2026-02-05","type":"pipeline","source":"BioPharma Dive","summary":"Novo, Lilly sputter as Hims launches knockoff GLP-1 pill - BioPharma Dive","headline":"Novo, Lilly sputter as Hims launches knockoff GLP-1 pill","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE11X0dLeEFiMFZQc1F4VnZuZE5JYmg5amFZNGhWZ2ZfS29BNjdIR0VXUVNTbGpXT2FvX1JfNzc3cWNyS05yZHVDLUpXLU5CLXR6VFBQTzM1UW5jQ1JKSmM3QXlWOXBpX0tabVNoY3poVzNPYXY4RDVkazVFbk1MQQ?oc=5","date":"2026-01-12","type":"deal","source":"Barron's","summary":"‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News. - Barron's","headline":"‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News. - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPdnp0eHp4N1llMkYzNzV5Skh1RHNJQVBJeFJHSHlUeFplTDRfRFBmSWI2VGgwNFNHdzhZRkt3dWxaMTBhTmZCaldodUdSMFpHUnVJX1YzSFZKMU1iTUdzQUpqWlJ0RThMOUNuZ25lZ2ppRi1BT21Bb2FtangyODhwc25QZWpkMTNxemltNWdxTU9hajdxVkxoalVicGI1Nzd0ZWdZQ29vU2xPWFY2SGdxUW9lZEx5WlQ1NXZ5Q2ZyQ3BneURMS29TeG9iN0NKTF9Qdy1MbUNZWnd5VUtOODExOENPS052UTlCYThMaw?oc=5","date":"2025-12-22","type":"trial","source":"prnewswire.com","summary":"AusperBio Completes Patient Enrollment in Phase III AUSHINE Study of AHB-137 for Chronic Hepatitis B - prnewswire.com","headline":"AusperBio Completes Patient Enrollment in Phase III AUSHINE Study of AHB-137 for Chronic Hepatitis B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxNRWFlc2ZWSTZseWZuRlJwakg3aWkxVzJhSW02bXd2SGZlYUxvejhaWHVYYUpIb3pYYXhGbHk2RTQ4RmR0elc1R2NHMzJWOERVUExvQVZwaW9CV0tnNWs1bFE5SENObzNKSVl2MS1OWUxSalRDcEVOUnpxRzhLMWVPNXVXdkVRVVotMERWOUdwSTNrd0JaMlhMYkVxZG9Jb29vbnBDWWFoZ3duc3lKMDFXcERubTAwWnQ4VTFzZHFOS0VIa3JZWFk1LV9WY205OVlFaGNJZ1ZFYVF3bUpQaEswellmRU5QOUpVem1LM3BQamVvOEdCNnZ0ZTRybnZkSW1rMmFINGNhdUxiMDI2T3pFTlRsZG43bVZLa0t1LXhLVERVcnAtbWc?oc=5","date":"2025-12-12","type":"pipeline","source":"prnewswire.com","summary":"AusperBio Announces AHB-137 Monotherapy Achieved 30% Functional Cure Rate in HBe-negative CHB Patients on Stable Nucleos(t)ide Analogue (NA) Therapy - prnewswire.com","headline":"AusperBio Announces AHB-137 Monotherapy Achieved 30% Functional Cure Rate in HBe-negative CHB Patients on Stable Nucleos","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-02","type":"patent","source":"The Economic Times","summary":"Biocon eyes Canadian bonanza from generics of weight-loss 'super-drugs' Ozempic and Wegovy - The Economic Times","headline":"Biocon eyes Canadian bonanza from generics of weight-loss 'super-drugs' Ozempic and Wegovy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNQzBIb3ZIZVdtYXZfRVJlY0dLdWRoZ3Y3eHR4UmJZdjZGRW1qZUZ5U0Q5b3FjR3hONGs2OUNmOGNwNndJQ2p0VF8wM1M1WHl0UzlTX3BDWHFVdmprN0ZKWlVKWXU1dXVSV2Y1SkZKR2U2OEwtQ085UHNEZGNXbENoVDF2MnVWdXlpN29xVWlkOGFOZjJrREcwR1JXVlRoZmtfTkNNeUdGR2ZueWRZQ09zcDRSRFk4YUozdmtGYUNTRkRubWU2RmpRR0lB?oc=5","date":"2025-02-13","type":"pipeline","source":"Fierce Healthcare","summary":"Hims & Hers sees 650% spike in traffic following Super Bowl ad as clash over compounded GLP-1s heats up - Fierce Healthcare","headline":"Hims & Hers sees 650% spike in traffic following Super Bowl ad as clash over compounded GLP-1s heats up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNZmhFWEFTQ3ZUYjBwaFZlQzJiWWdXYW9tVzFVbElEZjRsQUp4ZlpLdjBsaHVldUY5ZmhhM0Ixc1JXdmdXQjI2ODVMcldrMHEzM0Y1amxxTDdIZFF3Z0lPTUpFcjRRejl4Z2drSDNBdU5ISkUyX3Jla0xkd1lTdTlVR3JYeXVCWHNvWk5MQ2h3?oc=5","date":"2025-02-10","type":"pipeline","source":"Medical Marketing and Media","summary":"How pharma and health ads performed at Super Bowl 59 - Medical Marketing and Media","headline":"How pharma and health ads performed at Super Bowl 59","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOZTE3Rkl5eFNhMkNNeXIzQ0ZpMnVoMTAycGptZ3pUVlZBNHNibS1yLWF0dGJIVnRtZ24xVFpZU1ZBRnRvdl91bWR0OGsteHBRVzVQdUl0MU1SYTdQNTdYNVNQUE5CRzdqaGV2Rk1weW5mLW04ZmQzNlRma2Npc05icWdFbHBMUUdJejNWREdpVDNfcE13cWp6ZjRoejZVbWt0RjIzdFRB?oc=5","date":"2024-08-08","type":"pipeline","source":"Fierce Biotech","summary":"After a tough year, Exscientia folds into Recursion to create an AI superpower - Fierce Biotech","headline":"After a tough year, Exscientia folds into Recursion to create an AI superpower","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOQWRWQWwtOW1GS3pEQVFHWkhIc0YxUGtHWVU2a3NlRXZrYmcycmRTS1F5NGlId1dGOTVhVVI3enRwYzJHXzdleEx5bWs2bGs1MFhQWTBwZGx2YmVjbU9ySlpmWVdhbmk1UzhTRUEzWk9SbzFnbWtzUVJIQTJaaDMtQkhsUEM3ZWRGUlBWa3EzSk51Ump3QjdQNWZjbmRLQ0VvbS1j?oc=5","date":"2022-01-20","type":"pipeline","source":"Fierce Biotech","summary":"Super-resolution microscope maker Oni nabs $75M for US expansion - Fierce Biotech","headline":"Super-resolution microscope maker Oni nabs $75M for US expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNc09xZHY0TFFpc24yNzNFOHpvb2Frc1VqRm9pTVpwNTJPaVdwMTBfRnpUellxaExQRlJUWS1TcHh2WlltUkN4b1haMXRlVzZTNURrTEd4Mkx2RkNqb3FXeXdfZnZ5ckpVQXdxVVBXRDY3VmM3RWRCWFl0aGFkTkFqcUs4RDdxdTNQQkFIdDZ5TWhtSmlJMWRCazh6Z0x2MnRJUWhpMzlHM0FWOWpIUXA1am4wMVpkMHgzcFRDdmVOYWNBV1d6SHdXWDZTY01NWHFQLTBxeE9uel9DUUd1VjJTUEoyX1lrQnBuVU0xb1R4MjZpdkhONUxVeU9SVV9CRXItancyeV80WC1la2pScEdaNzRn?oc=5","date":"2013-11-28","type":"pipeline","source":"The Economic Times","summary":"Cadila Pharma working on super-bug NDM-1; soon to commercialize India's first VLP vaccine - The Economic Times","headline":"Cadila Pharma working on super-bug NDM-1; soon to commercialize India's first VLP vaccine","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}